Abbott Laboratories

Abbott Laboratories Beats on EPS, Stock Up 1.29%

Abbott Laboratories reported earnings that exceeded expectations on EPS, which contributed to a positive stock reaction, with shares rising by 1.29%. However, there was no revenue data or guidance provided, leaving some uncertainty about the company's future performance. Investors may be encouraged by the EPS beat but will likely look for more information in future reports.